Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Latin America Pharma and Healthcare Sector Report 2018/2022” report has been added to ResearchAndMarkets.com’s offering. This report provides…
How data and technology enable more patients to receive the most promising new experimental therapies during a clinical trial –…
ROCKVILLE, Md.–(BUSINESS WIRE)–NeoImmuneTech, Inc. (NIT), a T cell-focused immunotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA)…
– Full Results from Phase 3 ARTEMIS Study Will Be Featured – BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a…
ST. HELIER, Jersey–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24NVCR&src=ctag" target="_blank"gt;$NVCRlt;/agt; lt;a href="https://twitter.com/hashtag/Jefferies?src=hash" target="_blank"gt;#Jefferieslt;/agt;–Novocure (NASDAQ: NVCR) announced today that Bill Doyle, Novocure’s Executive Chairman, will…
DUBLIN–(BUSINESS WIRE)–The “India Pharma and Healthcare Sector Report 2019/2023” report has been added to ResearchAndMarkets.com’s offering. This report provides a…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…